• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchAtossa Therapeutics
    Picture of Atossa Therapeutics logo

    ATOS — Atossa Therapeutics News Story

    $1.960.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMicro CapNeutral
    • Market Cap
      $19.56m
    • Enterprise Value
      -$6.53m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • ATOS Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    ATOS Dividends
    All News

    NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM

    Picture of Atossa Therapeutics logoAtossa Therapeutics
    31/01/2026 24:00
    NASDAQ TRADE HALT  ATOS.O  HALT NEWS PENDING AT 07:50 PM
    

    Recent news on Atossa Therapeutics

    See all news
    • Atossa Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary

      10/11/2026 14:31
    • Atossa Therapeutics Q3 net loss narrows as clinical trial expenses decline

      10/11/2026 13:23
    • Brief: Atossa Therapeutics Executes Contingent Value Rights Agreement Providing Shareholders Participation In Potential Priority Review Voucher Value

      09/10/2026 13:13
    • US RESEARCH ROUNDUP-Amrize, Dexcom, Lennar

      01/10/2026 09:24
    • Atossa Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary

      10/08/2026 14:31

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.